In summary, we showed that tumor pVHL can be a promising target to induce “angiogenic switch off” in HCC and have demonstrated that SQAP can efficiently upregulates pVHL in HCC, which resulted in significant inhibition of tumor growth with inhibiting tumor angiogenesis. The gene discussed is VHL; the disease is hepatocellular carcinoma.